Home Complications of orthopedic treatment in patients diagnosed with X-linked hypophosphatemic rickets
Article
Licensed
Unlicensed Requires Authentication

Complications of orthopedic treatment in patients diagnosed with X-linked hypophosphatemic rickets

  • Carl Gustaf Paludan EMAIL logo , Kristoffer Koed Vittrup Thomsen , Ole Rahbek and Søren Kold
Published/Copyright: June 14, 2022

Abstract

Objectives

XLHR in children with a Rickets Severity Score ≥2 can now be treated with the new antibody drug, Burosumab, which prevents bone deformities and increases gait endurance. This study illustrates the extent of complications in the traditional orthopedic treatment of XLHR. The impact of surgery and severity of complications in this patient population has not been systematically assessed before.

Methods

The search strategy resulted in 215 studies and data were collected from 19 eligible studies and complications were categorized. Four medical charts of patients with XLHR at Aalborg University Hospital were assessed.

Results

One complication occurred on average per surgical procedure for XLHR in the published literature. The 168 reported complications were categorized as follows: Type I (n=79): Complications with minimal intervention required and treatment goal still achieved, Type II (n=41): Complications with substantial change in treatment plan and treatment goal still achieved, Type IIIA (n=23): Complications with failure to achieve treatment goal and no new pathology or permanent sequelae, Type IIIB (n=25): Complications with failure to achieve treatment goal and/or new pathology or permanent sequelae.

Conclusions

In average, one complication occurred per surgery and the severity of complications were substantial. The treatment goal was not achieved in 28% of surgeries whereof half of them resulted in permanent sequalae or new pathology. Our findings support the use of Burosumab for treatment of the skeletal changes in XLHR as the reported side-effects in Burosumab treatment appear negligible compared to the impact of surgeries and related complications (Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, et al. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet 2019;393:2416–27). However, orthopedic surgery might still be needed for correcting deformities restricting activities of daily living in XLHR patients.


Corresponding author: Carl Gustaf Paludan, Department of Orthopaedics, Interdisciplinary Orthopedics, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Nordjylland, Denmark, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Beck-Nielsen, SS, Brusgaard, K, Rasmussen, LM, Brixen, K, Brock-Jacobsen, B, Poulsen, MR, et al.. Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 2010;87:108–19. https://doi.org/10.1007/s00223-010-9373-0.Search in Google Scholar

2. Horn, A, Wright, J, Bockenhauer, D, Van’t Hoff, W, Eastwood, DM. The orthopaedic management of lower limb deformity in hypophosphataemic rickets. J Child Orthop 2017;11:298–305. https://doi.org/10.1302/1863-2548.11.170003.Search in Google Scholar

3. Lyseng-Williamson, K. Burosumab in X-linked hypophosphatemia: a profile of its use in the USA. Drugs Ther Perspect 2018;34:497–506. https://doi.org/10.1007/s40267-018-0560-9.Search in Google Scholar

4. Carpenter, TO, Whyte, MP, Imel, EA, Boot, A, Högler, W, Linglart, A, et al.. Burosumab therapy in children with X-linked hypophosphatemia. N Engl J Med 2018;378:1987–98. https://doi.org/10.1056/nejmoa1714641.Search in Google Scholar

5. Portale, A, Imel, EA, Whyte, MP, Boot, A, Högler, W, Linglart, A, et al.. Burosumab for X-linked hypophosphatemia (XLH): results from two pediatric phase 2 tri-als [abstract no. 525]. Endocr Pract 2018;24(1 Suppl):119–20. https://doi.org/10.1016/s1530-891x(20)47202-7.Search in Google Scholar

6. Danish Medicines Council. Baggrund for Medicinrådets anbefaling vedrørende burosumab som mulig standardbehandling til X-bundet hypofosfatæmi (XLH) hos børn og unge med skeletvækst; 2019. Available from: https://medicinraadet.dk/media/yzohk5on/medicinraadets-protokol-for-vurdering-af-burosumab-til-behandling-af-x-bundet-hypofosfataemi-xlh-version-10_adlegacy.pdf.Search in Google Scholar

7. National Institute for Health and Care Excellence. Burosumab for treating X-linked hypophosphataemia in children and young people. (Highly specialized technologies guidance. HST8); 2018. Available from: https://www.nice.org.uk/guidance/hst8 [Accessed 25 Nove 2021].Search in Google Scholar

8. Moher, D, Shamseer, L, Clarke, M, Ghersi, D, Liberati, A, Petticrew, M, et al.. PRISMA-P 2015 statement, 2015.Search in Google Scholar

9. Schardt, C, Adams, MB, Owens, T, Keitz, S, Fontelo, P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inf Decis Making 2007;7:16. https://doi.org/10.1186/1472-6947-7-16.Search in Google Scholar

10. Miller, SA, Forrest, JL. Enhancing your practice through evidence-based decision making: PICO, learning how to ask good questions. J Evid 2001;1:136–41. https://doi.org/10.1016/S1532-3382(01)70024-3.Search in Google Scholar

11. Black, S, Kwon, M, Cherkashin, A, Samchukov, M, Birch, J, Jo, C, et al.. Lengthening in congenital femoral deficiency: a comparison of circular external fixation and a motorized intramedullary nail. J Bone Jt Surg 2015;97:1432–40. https://doi.org/10.2106/jbjs.n.00932.Search in Google Scholar

12. Gizard, A, Rothenbuhler, A, Pejin, Z, Finidori, G, Glorion, C, Glorion, C, et al.. Outcomes of orthopedic surgery in a cohort of 49 patients with X-linked hypophosphatemic rickets (XLHR). Endocr Connect 2017;6:566–73. https://doi.org/10.1530/ec-17-0154.Search in Google Scholar

13. Kocaoglu, M, Bilen, FE, Sen, C, Eralp, L, Balci, HI. Combined technique for the correction of lower-limb deformities resulting from metabolic bone disease. J Bone Jt Surg Br Vol 2011;93:52–6. https://doi.org/10.1302/0301-620x.93b1.24788.Search in Google Scholar PubMed

14. Choi, I, Kim, J, Chung, C, Cho, T, Lee, S, Suh, S, et al.. Deformity correction of knee and leg lengthening by Ilizarov method in hypophosphatemic rickets: outcomes and significance of serum phosphate level. J Ped Orthop 2002;22:626–31. https://doi.org/10.1097/01241398-200209000-00011.Search in Google Scholar

15. Larson, AN, Trousdale, RT, Pagnano, MW, Hanssen, AD, Lewallen, DG, Sanchez-Sotelo, J, et al.. Hip and knee arthroplasty in hypophosphatemic rickets. J Arthroplasty 2010;25:1099–103. https://doi.org/10.1016/j.arth.2009.06.023.Search in Google Scholar PubMed

16. Novais, E, Stevens, P. Hypophosphatemic rickets: the role of hemiepiphysiodesis. J Pediatr Orthop 2006;26:238–44. https://doi.org/10.1097/01.bpo.0000218531.66856.b7.Search in Google Scholar PubMed

17. Ramseier, LE, Exner, GU, Neuhaus, TJ, Ulrich Exner, G, Fucentese, SF. Metabolic and orthopedic manage- ment of X-linked vitamin D-resistant hypophosphatemic rickets. J Child Orthop 2008;2:285–91. https://doi.org/10.1007/s11832-008-0118-9.Search in Google Scholar PubMed PubMed Central

18. Kanel, JS, Price, CT. Unilateral external fixation for corrective osteotomies in patients with hypophosphatemic rickets. J Pediatr Orthop 1995;15:232–5. https://doi.org/10.1097/01241398-199503000-00020.Search in Google Scholar

19. Rubinnovitch, M, Said, SE, Glorieux, FH, Cruess, RL, Rogala, E. Principles and results of corrective lower limb osteotomies for patients with vitamin D resistant hypophosphatemic rickets. Clin Orthop Relat Res 1988:264–70. https://doi.org/10.1097/00003086-198812000-00038.Search in Google Scholar

20. Rohmiller, MT, Tylkowski, C, Kriss, VM, Mier, RJ. The effect of osteotomy on bowing and height in children with X-linked hypophosphatemia. J Pediatr Orthop 1999;19:144–8. https://doi.org/10.1097/01241398-199901000-00024.Search in Google Scholar

21. Popkov, A, Aranovich, A, Popkov, D. Results of deformity correction in children with X-linked hereditary hypophosphatemic rickets by external fixation or combined technique. SICOT 2015;39:2423–31. https://doi.org/10.1007/s00264-015-2814-7.Search in Google Scholar PubMed

22. Song, H, Raju, SV, Kumar, S, Lee, S, Suh, S, Kim, J, et al.. Deformity correction by external fixation and or intramedullary nailing in hypophosphatemic rickets. Acta Orthop 2006;77:307–14. https://doi.org/10.1080/17453670610046073.Search in Google Scholar PubMed

23. Platzer, P, Thalhammer, G, Vecsei, V, Wozasek, G. Surgical treatment of femoral bending deformity in a patient with vitamin D-resistant rickets. Wien Klin Wochenschr 2005;117:721–4. https://doi.org/10.1007/s00508-005-0459-z.Search in Google Scholar PubMed

24. Stanitski, DF. Treatment of deformity secondary to metabolic bone disease with the Ilizartov technique. Clin Orthop Relat Res 1994;301:38–41. https://doi.org/10.1097/00003086-199404000-00007.Search in Google Scholar

25. Imel, EA, Glorieux, FH, Whyte, MP, Munns, CF, Ward, LM, Nilsson, O, et al.. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet 2019;393:2416–27. https://doi.org/10.1016/s0140-6736(19)30654-3.Search in Google Scholar


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpem-2021-0775).


Received: 2022-01-27
Accepted: 2022-05-23
Published Online: 2022-06-14
Published in Print: 2022-08-26

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review Article
  3. Effects of vitamin D supplementation on glycemic control of children and adolescents with type 1 diabetes mellitus: a systematic review
  4. Original Articles
  5. A preliminary study on the relationship between environmental endocrine disruptors and precocious puberty in girls
  6. Tissue concentration of aldosterone in fetal adrenals of intrauterine death cases
  7. Complications of orthopedic treatment in patients diagnosed with X-linked hypophosphatemic rickets
  8. Comparison of insulin sensitivity indices for detection of double diabetes in Indian adolescents with type 1 diabetes
  9. Evaluation of the growth and nutritional status of preschool children: a pilot study in the cold area of China
  10. Arterial hypertension is associated with an increased risk of metabolic complications in pediatric patient with obesity
  11. From pregnancy to breastfeeding: adequate maternal body mass index is essential to prevent a high body mass index in your children
  12. Screening of non-syndromic early-onset child and adolescent obese patients in terms of LEP, LEPR, MC4R and POMC gene variants by next-generation sequencing
  13. The association between vitamin B12, folate, homocysteine levels, and carotid intima-media thickness in children with obesity: a cross-sectional study
  14. Comprehensive assessment of cardiovascular disease risk in children with short stature due to isolated growth hormone deficiency: a case-control study
  15. Visceral adiposity is related to insulin sensitivity and inflammation in adolescents with obesity and mild sleep disordered breathing
  16. Recurrent hypoglycemic seizure as a presenting symptom of post-TBI hypopituitarism in children: a case report, review and proposed protocol
  17. Evaluation of the etiological and clinical characteristics of pediatric central diabetes insipidus
  18. Case Reports
  19. Clinical and radiologic evaluation of a Turkish family with hypochondroplasia and a rare FGFR3 variant
  20. Rituximab therapy in ROHHAD(NET) syndrome
  21. Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with zoledronic acid and Denosumab
  22. A 2-bp deletion mutation in SMPD1 gene leading to lysosomal acid sphingomyelinase deficiency in a Chinese consanguineous pedigree
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2021-0775/html
Scroll to top button